Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice

  1. Pierzynowska, K.
  2. Deshpande, A.
  3. Mosiichuk, N.
  4. Terkeltaub, R.
  5. Szczurek, P.
  6. Salido, E.
  7. Pierzynowski, S.
  8. Grujic, D.
Aldizkaria:
Frontiers in Medicine

ISSN: 2296-858X

Argitalpen urtea: 2020

Alea: 7

Mota: Artikulua

DOI: 10.3389/FMED.2020.569215 GOOGLE SCHOLAR lock_openSarbide irekia editor